| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/02/2006 | WO2005105833A3 Novel herpes simplex viruses and uses thereof |
| 02/02/2006 | WO2005105789A3 Novel pyrrole derivatives with angiotensin ii antagonist activity |
| 02/02/2006 | WO2005105116A3 Inhibition of biogenic sulfide production via biocide and metabolic inhibitor combination |
| 02/02/2006 | WO2005105059B1 Permeation enhancer comprising genus curcuma or germacrone for transdermal and topical administration of active agents |
| 02/02/2006 | WO2005097122A3 Method of treating schizophrenia and/or glucoregulatory abnormalities |
| 02/02/2006 | WO2005094899A8 Clusterin antisense therapy for treatment of cancer |
| 02/02/2006 | WO2005092890A3 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof |
| 02/02/2006 | WO2005089100A3 Decontamination formulations for disinfection and sterilization |
| 02/02/2006 | WO2005084296A3 Fused tricyclic compounds as inhibitors of 17beta-hydroxysteroid dehydrogernase 3 |
| 02/02/2006 | WO2005070052A3 Use of photodynamic therapy to enhance treatment with immuno-modulating agents |
| 02/02/2006 | WO2005070024A3 Treatment of cancer using benzoic acid derivatives |
| 02/02/2006 | WO2005068487A3 Processes for the preparation of rocuronium bromide and intermediates thereof |
| 02/02/2006 | WO2005067906A3 Pharmaceutical composition comprising 2,4-dichlorobenzyl alcohol and amylmetacresol |
| 02/02/2006 | WO2005065372A3 Methods and compositions using thalidomide for the treatment and management of central nervous system disorders or diseases |
| 02/02/2006 | WO2005058230A3 Topical use of halosalicylic acid derivatives |
| 02/02/2006 | WO2005056056A3 The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist |
| 02/02/2006 | WO2005044247A8 Pharmaceutical composition containing guaiacol derivatives and syringol derivatives extracted from natural plant vinegar |
| 02/02/2006 | WO2005003301A3 Methods, compositions, and kits for predicting the effect of compounds on hot flash symptoms |
| 02/02/2006 | WO2004110347A3 Compositions and methods for reducing scar tissue formation |
| 02/02/2006 | WO2004103286A3 Compositions of a cyclooxygenase-2 selective inhibitor and a cholimergic agent |
| 02/02/2006 | WO2004098520A3 Compounds and compositions as protein kinase inhibitors |
| 02/02/2006 | WO2004093801A3 Pharmaceutical products |
| 02/02/2006 | WO2004092352A3 Disruption of the reg pathway |
| 02/02/2006 | WO2004091540A3 Methods of treating pain and compositions for use therefor |
| 02/02/2006 | US20060026700 Tissue specific genes and gene clusters |
| 02/02/2006 | US20060025619 Methods of using 2-methoxyestradiol of high purity |
| 02/02/2006 | US20060025600 Process for preparing zolmitriptan compounds |
| 02/02/2006 | US20060025597 4-(Aminomethyl)-2-(2,6-dioxo(3-piperidyl))isoindoline-1,3-dione hydrochloride; cytokines level reduced; tumor necrosis factor inhibitors; nontoxic; anticarcinogenic agents; antitumor agents (solid/blood-borne); cardiovascular disorders; osteoporosis; antiinflammatory agents; autoimmune diseases |
| 02/02/2006 | US20060025594 Small molecule entry inhibitors |
| 02/02/2006 | US20060025590 Novel compounds |
| 02/02/2006 | US20060025584 Crystallization of polyol compositions, crystalline polyol composition product and use thereof |
| 02/02/2006 | US20060025581 Novel human GABA receptor proteins and polynucleotides encoding the same |
| 02/02/2006 | US20060025486 Compositions containing policosanol and B vitamins and their pharmaceutical uses |
| 02/02/2006 | US20060025485 Hydroxybenazamide compounds for treatment of cancer |
| 02/02/2006 | US20060025484 Use of 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)urea for treatment of pancreatic carcinomas, soft tissue sarcomas, testicular tumors, lymphomas, thymomas, wilms' tumors, renal carcinomas, melanomas, lung tumors, intracerebral metastases, tumors in the head and neck area and mammary carcinomas |
| 02/02/2006 | US20060025483 (-)-Hydroxycitric acid for protection against soft tissue and arterial calcification |
| 02/02/2006 | US20060025482 (-)-Hydroxycitric acid for the modulation of angiotensin-converting enzyme |
| 02/02/2006 | US20060025481 Process for preparation of probucol derivatives and polymorphic forms thereof |
| 02/02/2006 | US20060025480 Benzoic acid derivatives as non nucleoside reverse transcriptase inhibitors |
| 02/02/2006 | US20060025479 Agents with leukotriene B4-like antiviral (enveloped RNA) activities |
| 02/02/2006 | US20060025478 Medicine for prevention or treatment of diabetes |
| 02/02/2006 | US20060025477 Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseases |
| 02/02/2006 | US20060025476 Use of methyl pyruvate for the purpose of reducing weight gain in mammals. |
| 02/02/2006 | US20060025475 Use of methyl pyruvate for the purpose of increasing muscle energy production. |
| 02/02/2006 | US20060025474 Bisphenyl compounds useful as vitamin D3 receptor agonists |
| 02/02/2006 | US20060025473 Pharmaceutical formulations containing substituted 2 heteroarylaminoacetic acid compounds |
| 02/02/2006 | US20060025471 Xanthenyl cubane analogs with activity at the metabotropic glutamate receptors |
| 02/02/2006 | US20060025470 Contacting a base with an enantiomerically pure hydroxyl group containing compound, reacting the product with a nitro, fluoro-containing benzene compound, reducing the product to the corresponding amine |
| 02/02/2006 | US20060025469 Methods for decreasing beta amyloid protein |
| 02/02/2006 | US20060025468 Chiral pyrrolidine derivatives, and methods for preparing compounds thereof |
| 02/02/2006 | US20060025467 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitors |
| 02/02/2006 | US20060025466 E.g., N-[1-cyano-1-methyl-2-(5-nitroindazol-1-yl)-ethyl]-4-trifluoromethoxybenzamide; especially suitable for controlling parasites such as helminthes on warm-blooded animals. |
| 02/02/2006 | US20060025465 Process for preparing substituted imidazole derivates and intermediates used in the process |
| 02/02/2006 | US20060025464 Benzimidazole derivatives as therapeutic agents |
| 02/02/2006 | US20060025463 Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases |
| 02/02/2006 | US20060025461 Triazole derivative |
| 02/02/2006 | US20060025460 isoxazolidine compounds, that B-cell lymphoma (BCL) proteins and block Bcl antiapoptotic function in cancer cells and tumor tissue; anticarcinogenic agents |
| 02/02/2006 | US20060025459 Having Asp2 ( beta -secretase, BACE1 or Memapsin) inhibitory activity, for therapy of diseases characterised by elevated beta -amyloid levels or beta -amyloid deposits |
| 02/02/2006 | US20060025458 Alkylammonium compounds as antifungal and antitrypanosomal agents |
| 02/02/2006 | US20060025457 Isoindoline compounds and methods of their use |
| 02/02/2006 | US20060025456 Serotonin reuptake inhibitors; dimethyl-(2-pyridin-3-yl-cyclohex-1-enylmethyl)-amine and the corresponding dihydrochloride; analgesics, anxiety disorders; side effects reduction |
| 02/02/2006 | US20060025455 New 5-aryl pyridines as 11-beta inhibitors for the treatment of diabetes |
| 02/02/2006 | US20060025454 Prenylation inhibitors and methods of their synthesis and use |
| 02/02/2006 | US20060025453 inhibitor for treating a chemokine mediated disease; cancer, angiogenesis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and cardiac reperfusion injury, pain |
| 02/02/2006 | US20060025452 Method of treating demyelinating diseases or conditions |
| 02/02/2006 | US20060025451 Novel pyrazole compounds as transforming growth factor (TGF) inhibitors |
| 02/02/2006 | US20060025450 Use of an H+, K+ -ATPase inhibitor in the treatment of asthma |
| 02/02/2006 | US20060025449 Use of N-substituted imino sugars for appetite suppression |
| 02/02/2006 | US20060025448 Hair growth stimulators |
| 02/02/2006 | US20060025447 6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-halo ro sulfonyl or N-chlorosuccinimides with a magnesium compound in presence of trichloromethane solvent to form an intermediate, reacting with a base; agents for the treatment of inflammatory and immune-cell mediated diseases |
| 02/02/2006 | US20060025446 Propargyl nitroxides and indanyl nitroxides and their use for the treatment of neurologic diseases and disorders |
| 02/02/2006 | US20060025445 11-Beta HSD1 inhibitors |
| 02/02/2006 | US20060025444 Fexofenadine base polymorphic forms |
| 02/02/2006 | US20060025443 3(3-methoxyphenyl)-3-(3-dimethylaminopropyl)-4,4-dimethylpiperidine-2,6-dione pamoate; serotonin receptor antagonist; antidepressant, anxiolytic agent; migraine and sleep apnoea; weight loss and hepatocyte changes |
| 02/02/2006 | US20060025442 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 02/02/2006 | US20060025441 Bipiperidinyl derivatives useful as inhibitors of chemokine receptors |
| 02/02/2006 | US20060025440 Hydrophobic, hydrophilic wound composition for delivery of pharmaceutical(s) to wet surfaces or in aqueous environments |
| 02/02/2006 | US20060025439 Hydrophobic, hydrophilic wound composition for delivery of pharmaceutical(s) to wet surfaces or in aqueous environments |
| 02/02/2006 | US20060025438 Amine-based and amide-based inhibitors of semicarbazide-sensitive amine oxidase (SSAO) enzyne activity and VAP-1 mediated adhesion useful for treatment of diseases |
| 02/02/2006 | US20060025437 SNS-595 and methods of using the same |
| 02/02/2006 | US20060025436 Enantioselective preparation; ligands for the estrogen receptor; to prevent chronic inflammatory diseases without stimulating uterine and breast cell proliferation; 4-{[(6S)-8-Fluoro-6-methylphenanthridin-5(6H)-yl]sulfonyl}phenyl sulfamate |
| 02/02/2006 | US20060025435 Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 02/02/2006 | US20060025434 Therapeutic agents for drug/substance dependence |
| 02/02/2006 | US20060025433 Pyrimidine derivatives useful as inhibitors of PKC-theta |
| 02/02/2006 | US20060025432 N-[2-[(3-Chloro-2-fluorobenzyl)thio]-6-[(2-hydroxy-1-methylethyl)amino]-4-pyrimidinyl]- 4-morpholinesulfonamide; asthma, antiallergens; rhinitis, chronic obstructive pulmonary disease, inflammatory bowel disease, irritable bowel syndrome, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis |
| 02/02/2006 | US20060025431 E.g., 1'-[(2S)-2-Hydroxy-2-phenylethyl]-8'-pyridin-4-yl-3',4'-dihydrospiro[cyclopropane-1,2'-pyrimido[1,2-a]pyrimidin]-6'(1'H)-one; treating non-insulin dependent diabetes |
| 02/02/2006 | US20060025430 Novel irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and uses thereof for therapy and diagnosis |
| 02/02/2006 | US20060025429 Composition and methods for inhibiting expression of hypoxia-inducible genes |
| 02/02/2006 | US20060025428 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 02/02/2006 | US20060025427 Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
| 02/02/2006 | US20060025426 controlling signal transduction; anticancer agents; angiogenesis inhibitors; vision defects; cardiovascular disorders; antidiabetic agents; antiischemic agents; antiinflamamtory agents |
| 02/02/2006 | US20060025425 Benzimidazole and pyridylimidazole derivatives |
| 02/02/2006 | US20060025424 topoisomerase inhibitors such as [5-(4-Cyclopropylcarbamoyl-imidazol-1-yl)-7-pyrimidin-2-yl-1H-benzoimidazol-2-yl]-carbamic acid ethyl ester, used for prophylaxis of bacterial infections in mammals |
| 02/02/2006 | US20060025423 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma |
| 02/02/2006 | US20060025422 Remedy for integration dysfunction syndrome |
| 02/02/2006 | US20060025421 Pyridyl piperazines for the treatment of CNS disorders |
| 02/02/2006 | US20060025420 Pharmaceutical compositions for the treatment of female sexual disorders |
| 02/02/2006 | US20060025419 Imidazoquinoxaline compound for the treatment of melanoma |
| 02/02/2006 | US20060025418 Methods of making and using N-desmethylzopiclone |
| 02/02/2006 | US20060025417 Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |